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Summary: It is demonstrated that uranyl ions remaining in deproteinized supernatants of blood, serum, or liquor cere-
brospinalis lead to falsely elevated glucose values by forming insoluble precipitates of uranyl phosphate. Furthermore,
glucose is overestimated in hemolytic blood samples because of the UV-absorption of incompletely precipitated
hemoglobin. A modified deproteinization method is recommended which overcomes these problems: the specimen
volume is reduced to one half of the usual volume (0.05 instead of 0.1 ml) and excess uranyl ions are removed from
the deproteinized supernatant by precipitation as uranyl phosphate, using phosphate-coated tubes. The supernatant
obtained after centrifugation is free of uranyl ions and hemoglobin. Therefore, a sample blank may be omitted.
Überhöhte Glucosewerte in Uranylacetat-behandelten Proben: Modifikation der Enteiweißungsmethode
Zusammenfassung: Ein Überschuß an Uranylionen in enteiweißten Überständen von Blut, Serum oder Liquor führt
durch Ausfallung unlöslichen Uranylphosphats bei der Glucosebestimmung zu falsch hohen Ergebnissen. Unvoll-
ständige Enteiweißung hämolytischer Blutproben verursacht aufgrund der Eigenextinktion des Hämoglobins eben-
falls überhöhte Glucosewerte. Es wird deshalb eine modifizierte Enteiweißungsmethode vorgeschlagen. Das Proben-
volumen wird auf die Hälfte des üblichen Volumens reduziert (0,05 statt 0,1 ml). In phosphat-beschichteten Gefäßen
werden anschließend überschüssige Uranylionen als Uranylphosphat ausgefällt. Der so erhaltene Überstand ist frei von
Hämoglobin und Uranylionen und kann ohne Berücksichtigung eines Probenleerwerts für die Glucosebestimmung
Verwendet werden.
Introduction
Uranyl acetate is widely used as a deprpteimzing agent
for blood glucose determination. It is effective at low
concentrations and easier to.handle than strong acids,
e.g. perchloric acid. Polysaccharides are not hydrolyzed
(1) and protein precipitates can be centrifuge d at a
relatively low speed (2). Recently, however, it was
reported that uranyl acetate disturbs blood glucose
determination at low sample protein concentrations (3).
Materials and Methods
All reagents were from Merck, Darmstadt, except Glucoquant
and GOD-Perid test combinations, uranyl acetate solution,
perchloric acid, and Precinorm S (Boehringer, Mannheim),
bovine serum albumin (Behring, Marburg) Monitrol I-X,
Monitrol II, and human hemoglobin standard (Merz and Dade,
Miami), and Pathonorm low and high (Molter, Heidelberg).
Procedure
If not otherwise stated, deproteinization of blood, liquor cere-
brospinalis, or control sera (0.1 ml each) was achieved by
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addition of 1 ml of either 0.33 mol/1 perchloric acid or 3.8 mmpl/1
uranyl acetate. The precipitate was spun down within 2 min at
10 000 £ (perchloric acid) or 3000 g (uranyl acetate). The super-
natant was transferred to a plastic tube of the type used in the
Eppendorf substrate analyzer (Substratautomat 5031) for
glucose determination by the glucose dehydrogenase method
(2). The tube was recentrifuged prior to assay (3000 g, 0.5 min)
in order to remove the few erythrocytes which had been trans-
ferred together with the supernatant. For control experiments,
the hexokinase (4) and glucose oxidase methods (1) were used.
Protein and hemoglobin were determined by standard procedures
(5,6).
Results and Discussion
Deproteinization of samples with low protein contents
Figure 1 demonstrates the poor agreement of glucose
values determined after deproteinization by uranyl acetate
and perchloric acid, respectively. Only at protein concen-
trations higher than 50 g/1 do both methods yield identical
results (fig. 2).
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Fig. l. Glucose concentrations measured in control sera
(left) and biological fluids (right) after deproteiniza-
tion by perchloric acid (abscissa) or uranyl acetate
(ordinate), respectively. Filled symbols: undiluted
samples. Open symbols: samples diluted 1:2.
Numbered circles = control sera (1 = Monitrol I-X,
2 = Monitrol II, 3 = Pathonorm High, 4 = Pathonorm
Low, 5 = Precinorm S), squares = liquor cerebrospinalis
(6, 7), triangels = blood (8-15). The dotted line repre-
sents the graph of χ = y.
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Fig. 2. Differences of glucose values (Δ glucose) determined
in control sera (left) and biological fluids (right) after
precipitation of varying amounts of protein by either
perchloric acid or uranyl acetate. For symbols see
figure 1.
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It was demonstrated by measurements of the absorption
spectra of uranyl acetate and deproteinized sample super-
natants that at low protein concentrations an excess of
uranyl ions remains in solution. Falsely elevated glucose
values were proved to be the consequence of the turbidity
caused by insoluble uranyl phosphate crystals (7), which
were formed in the test tube in the presence of phosphate
buffer. Precipitates were also obtained when the phosphate
buffer was replaced by triethanolamine-HCI, Tris-HCl, or
irriidaz le-HCl buffers, but not when triethanolamine.
tartrate or imidazole-tartrate buffers were used. In the
latter buffers, however, the activity of glucose dehydro-
genase was markedly reduced as compared to phosphate
buffer and, in addition, the uranyl tartrate complex
formed (8) showed a very high absorption at 334 nm.
Using the hexokinase or glucose oxidase method, where
phosphate buffer is also included in the tek medium, the
correct glucose content of a low protein serum (Patho-
norm low) was measured (1.4 mmol/l), most probably
because of the low sample volume added to the test
volume. When reagent and sample volumes were the
same as those used in the glucose dehydrogenase method
(0.5 rnl reagent + 0.05 ml deproteinized sample) and
when the same incubation temperature (37 °C) and
vigorous stirring procedure was applied, 30—40 % over-
estimation of glucose was observed in the two control
methods. The formation of uranyl phosphate was found
to be enhanced by high temperature and stirring of the
solution, conditions which are common to automated
methods.
Complete removal of surplus uranyl ions from the depro-
teinized sample was achieved by precipitation of uranyl
ions with phosphate prior to the glucose assay. 20 Mmples
of sodium ammonium hydrogenphosphate (which is less
hygroscopic than other soluble phosphates) were pipetted
as a 1 mol/1 solution into plastic tubes and dried at 40 °C
overnight1).
Deproteinized samples were transferred to these phos-
phate-coated tubes, centrifuged as usual without further
shaking and then analyzed in the Eppendorf substrate
analyzer. Removal of uranyl ions by this procedure was
sufficient, as indicated by the good agreement between
glucose concentrations measured in these samples as
compared to those deproteiriized with perchloric acid
(fig. 3).
Deproteinization of hemolytic blood samples
In hemolytic blood the protein concentration may be
more than doubled by free hemoglobin. At a final con-
centration of about 4 mmol/l which is routinely used,
the precipitating capacity of uranyl acetate is rather
1) Coated tubes are commercially available from Sarstedt, Niim-
br echt, Germany.
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Fig. 3. Glucose concentrations measured in control sera
(left) and biological fluids (right) after standard de-
proteinization by perchloric acid (abscissa) or by the
modified uranyl acetate method (ordinate). For symbols
see figure 1. Numbers 6-15 indicate identical specimens
in all 3 figures.
Tab. 1. Precipitation of different proteins by uranyl acetate
(0.1 ml protein solution + 1 ml uranyl acetate solution).
The first column gives the protein concentration (bovine
serum albumin, Monitrol I-x) or the hemoglobin con-
centration (human hemoglobin standard), respectively.
Values are means of 2 determinations.
Protein concen-
tration
(g/D
40
60
80
120
160
Percentage precipitated
Albumin
100
100
100
100
100
Hemoglobin
83
39
22
00
00
Monitrol
99
99
100
93
89
limited. It is shown in table 1 that even low amounts of
hemoglobin are not completely precipitated under these
conditions. Free hemoglobin leads to overestimation of
glucose due to its absorption in the UV-range.
If, however, only 0.05 ml of hemolytic blood instead
of 0.1 ml were added to 1 ml of uranyl acetate for de-
proteinization, hemoglobin precipitation was complete,
despite total hemolysis. The excess of uranyl ions was
sufficiently removed from the supernatant by phosphate
precipitation as described above, so that glucose values
corresponded well to those measured in non-hemolytic
blood (tab. 2).
Considering the results of our study the following
deproteinization method is recommended. 0.05 ml of
whole blood, serum, or liquor cerebrospinalis are added
to 1 ml of uranyl acetate. The sample is centrifuged for
2 min at 3 000 £ and the clear supernatant is trans-
ferred to another tube containing about 20 μιηοΐ of dried
sodium ammonium hydrogen-phosphate. After centri-
fugation (0.5 min at 3 000 g) the supernatant is used for
glucose determination. This procedure warrants complete
deproteinization of normal and hemolytic blood samples
and removes excess uranyl acetate from the supernatant.
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Tab. 2. Glucose determination by the glucose dehydrogenase method (2) in 10 hemolytic blood specimens. Hemolysis was achieved by
freezing twice in liquid nitrogen and subsequent thawing at 37 °C. 2 Deproteinization methods (0.1 ml blood and 0.05 ml blood,
respectively, + 1 ml uranyl acetate) were compared. For removal of excess uranyl ions with phosphate see text. Reference
Values before and after hemolysis were obtained after deproteinization with perchloric acid.
Number of sample
1 !
2
3
4
5
6
7
8
9
10
Hemoglobin
total
hemoglobin
104
• 143
145
146
125
127
138
100
110
132
concentration fe/1)
Free
hemoglobin
after
hemolysis
101
134
137
139
122
121
132
96
106
126
Glucose concentration (mmol/l)
Before
hemolysis
7.6
4.4
6.7
6.9
7.5
5.6
4.2
13.4
11.4
6.1
After hemolysis
Deproteinization
Perchloric
acid
7.7
4.4
6.8
7.2
7.9
5.9
4.3
13.6
11.4
6.1
with
Uranyl acetate
Routine method
19.7
17.7
10.4
24.2
19.7
21.6
13.3
20.6
22.0
14.3
Modified method
7.6
4.7
7.1
7.2
7.8
6.1
4.4
13.7
11.4
6.3
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